Clinical profile of clozapine: adverse reactions and agranulocytosis.
about
Blood lactate levels in patients receiving first- or second- generation antipsychotics.N-oxidation of drugs associated with idiosyncratic drug reactions.Serum clozapine levels: a review of their clinical utility.Atypical Antipsychotic Use in the Treatment of Psychosis in Primary CareA review of clozapine safety.Clozapine-related EEG changes and seizures: dose and plasma-level relationships.Adverse effects of clozapine in older patients: epidemiology, prevention and management.Seizure associated with clozapine: incidence, etiology, and management.Trends in the prescription of clozapine in a psychiatric hospital: a 5-year observational study.Hepatic Safety of Atypical Antipsychotics: Current Evidence and Future Directions.Is clozapine safe in the elderly?Sialorrhea and aspiration pneumonia: a case study.How reliable are reported plasma clozapine levels?Sudden late onset of clozapine-induced agranulocytosis.Potential clozapine target sites on peripheral hematopoietic cells and stromal cells of the bone marrow.Cardiovascular side effects of novel antipsychotics.Severe tachycardia following low-dose clozapine treatment.Five-year follow-up during antipsychotic treatment: efficacy, safety, functional and social outcome.Role of MKP-1 (DUSP1) in clozapine-induced effects on the ERK1/2 signaling pathway in the rat frontal cortex.
P2860
Q34613859-B65A636A-2956-49CC-A4BD-3231C6D06B85Q34819168-89E148D9-16C0-4F98-AD50-243FF1FD6F14Q35180807-4B0CC930-E7F2-41AC-AAC4-DAFBAB56782DQ35665593-2205C5DA-D31C-4186-9775-E8FF7FF30BCEQ36191044-A292AD93-DB48-4B4C-8956-AA93A708850CQ37078947-3952A9DE-2176-4C25-AAE9-A08B0D38DECFQ38171350-AC9D6DEA-1169-4E64-81C2-AE39DC46AB30Q38299304-C43F4ABE-3B33-45F8-A02F-6F8CEA463A68Q38646571-3FBA489A-9227-4F2E-AC8E-4F95BB807466Q38838664-0468E653-37A6-49C7-9A97-F026D009DAEEQ41534094-41A8964F-E269-4E6A-8251-4CB4FB58EAD6Q42130700-02236ECD-2F6D-446A-8D1C-ED8FB1AF97F5Q43725456-FD3D82F7-8C4E-429D-8BCF-1FA082ADF6CBQ44001931-96F4C8B6-A4AA-4DC1-B486-1253336EE256Q44557820-82A7B855-D857-4FB0-9142-F046C859D021Q45029832-E5A128ED-FF94-4541-9E8F-778D868D5DCFQ46389799-CB99B809-DD13-4483-9F8B-A3940ED99BE8Q46937654-7EC58D18-D982-4C36-BDC4-4B069234BC19Q50903681-2F5E81C5-3D4B-4E6D-ACA5-7B915B7F07E0
P2860
Clinical profile of clozapine: adverse reactions and agranulocytosis.
description
1992 nî lūn-bûn
@nan
1992 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Clinical profile of clozapine: adverse reactions and agranulocytosis.
@ast
Clinical profile of clozapine: adverse reactions and agranulocytosis.
@en
type
label
Clinical profile of clozapine: adverse reactions and agranulocytosis.
@ast
Clinical profile of clozapine: adverse reactions and agranulocytosis.
@en
prefLabel
Clinical profile of clozapine: adverse reactions and agranulocytosis.
@ast
Clinical profile of clozapine: adverse reactions and agranulocytosis.
@en
P2860
P356
P1476
Clinical profile of clozapine: adverse reactions and agranulocytosis.
@en
P2093
Lieberman JA
Safferman AZ
P2860
P2888
P356
10.1007/BF01064682
P577
1992-01-01T00:00:00Z